3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Other solid neoplasm
1
Gastrointestinal
1
Conditions
Colorectal Neoplasms
105
Carcinoma, Hepatocellular
34
Gastrointestinal Stromal Tumors
17
Colonic Neoplasms
14
Rectal Neoplasms
12
Neoplasm Metastasis
12
Liver Neoplasms
8
Stomach Neoplasms
5
Cholangiocarcinoma
5
Pancreatic Neoplasms
4
Esophageal Neoplasms
4
Sarcoma
3
Parkinson Disease 4, Autosomal Dominant Lewy Body
3
Colorectal Cancer Metastatic
3
Carcinoma, Renal Cell
3
Advanced Colorectal Cancer
3
Squamous Cell Carcinoma of Head and Neck
2
Small Cell Lung Carcinoma
2
Neoplasms
2
Mesothelioma, Malignant
2
Melanoma
2
Lung Neoplasms
2
Glioblastoma
2
Gastrointestinal Neoplasms
2
Gallbladder Neoplasms
2
Fatigue
2
Esophageal Squamous Cell Carcinoma
2
Colorectal Cancer Liver Metastases
2
Carcinoma, Transitional Cell
2
Carcinoma, Non-Small-Cell Lung
2
Interventions
Fluorouracil
26
Radiotherapy
18
Mitomycin
17
Cisplatin
12
Capecitabine
12
pembrolizumab
10
Magnetic Resonance Spectroscopy
9
Cyclophosphamide
9
Radiation
8
Paclitaxel
8
Biopsy
8
fludarabine
7
Specimen Handling
7
Nivolumab
7
Drug Therapy
7
Carboplatin
7
Surveys and Questionnaires
6
Cetuximab
6
Papillomavirus Vaccines
5
dehydroftorafur
4
aldesleukin
4
Vaccines
4
Radiotherapy, Intensity-Modulated
4
Observation
4
Irinotecan
4
Watchful Waiting
3
Taxes
3
Oxaliplatin
3
Light Coagulation
3
Ipilimumab
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Anus Neoplasms
×
regorafenib
×
Gastrointestinal
×
Clear all
NCT05582031
2023-06-07
REFIT-MSS
Translational Research in Oncology
Phase 2
Withdrawn